Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment

American Journal of Ophthalmology

Volumn 127, Issue 1, 1999, Pages 102-104

  Hwang, Jeong Min ^a,c   Girkin, Christopher A ^a   Perry, Julian D ^a   Lai, James C ^a   Miller, Neil R ^a   Hellmann, David B ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c Seoul National University Boramae Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE;

AGED; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; FEMALE; GIANT CELL ARTERITIS; HUMAN; OCULAR ISCHEMIC SYNDROME; PRIORITY JOURNAL; TREATMENT FAILURE; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0032901585     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(98)00313-4     Document Type: Article

References (5)

1. Ghanchi F.D., Dutton G.N. Current concepts in giant cell (temporal) arteritis. Surv Ophthalmol. 42:1997;99-123.
2. Galetta S.L. Vasculitis. Miller N.R., Newman N.J. 5th Edition Walsh and Hoyt's clinical neuro-ophthalmology. Volume 3:1998;3755-3782 Williams & Wilkins, Baltimore.
3. Hayreh S.S., Podhajsky P.A., Zimmerman B. Am J Ophthalmol. 125:1998;509-520.
4. Hamed L.M., Guy J.R., Moster M.L., Bosley T. Giant cell arteritis in the ocular ischemic syndrome. Am J Ophthalmol. 113:1992;702-705.
5. Liu G.T., Glaser J.S., Schatz N.J., Smith J.L. Visual morbidity in giant cell arteritis: clinical characteristics and prognosis for giant cell arteritis. Ophthalmology. 101:1994;1779-1785.